Extracellular Vesicles

Vanquish Bio utilizes the biological mechanisms of natural killer (NK) cell-derived extracellular vesicles (EVs) as novel therapy. NK cell-mediated cytotoxicity includes CD9 expression enhances the susceptibility of myeloma cell lines to cell-mediated cytotoxicity. NK extracellular vesicles contain ligase molecules involved in anti-cancer cytolytic functions, underlying NK cell-mediated killing, serving to control tumor dissemination and metastasis, resulting to reduced progression and spread.